Jpmorgan Chase & CO Heska Corp Transaction History

Jpmorgan Chase & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	BUY	$62.17 - $97.62 $769,540 - $1.21 Million	12,378 Added 52.05%	36,159 $3.53 Million
Q1 2023 May 11, 2023	SELL	$62.17 - $97.62 $650,236 - $1.02 Million	-10,459 Reduced 30.55%	23,781 $2.32 Million
Q4 2022 Feb 13, 2023	BUY	$60.21 - $77.74 $19,146 - $24,721	318 Added 0.94%	34,240 $2.13 Million
Q3 2022 Nov 14, 2022	SELL	$72.92 - $99.73 $99,462 - $136,031	-1,364 Reduced 3.87%	33,922 $2.47 Million
Q2 2022 Aug 11, 2022	BUY	$84.23 - $147.57 $30,491 - $53,420	362 Added 1.04%	35,286 $3.34 Million
Q1 2022 May 11, 2022	BUY	$122.89 - $171.74 $22,120 - $30,913	180 Added 0.52%	34,924 $4.83 Million
Q4 2021 Feb 10, 2022	BUY	$156.0 - $265.78 $595,452 - $1.01 Million	3,817 Added 12.34%	34,744 $6.34 Million
Q3 2021 Nov 12, 2021	BUY	$228.69 - $274.2 $7.07 Million - $8.48 Million	30,927 New	30,927 $8 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.